Abstract

BackgroundCD4+interferon (IFN)-γ+ T cell (Th1) and CD4+interleukin (IL)-4+ T cell (Th2) polarizations are crucial in the pathogenesis of graft-versus-host disease (GVHD). However, this hypothesis is largely based on animal experiments of Parent-into-F1 GVHD model. The causal relationship between kinetics of Th1, Th2 and associated cytokines and the clinical activity of GVHD in a real world situation remains unknown.MethodologyPeripheral blood was collected every week prospectively from Day 0 to Day 210 (patients without GVHD) or Day 300 (patients with chronic GVHD) after allogeneic peripheral blood stem cell transplantation in consecutive 27 patients. The frequencies of Th1 and Th2 within CD4+ T cells were determined by flow cytometry and pplasma IFN-γ, IL-12, IL-4, and IL-10 were determined by ELISA.Principal FindingsKinetics of Th1, Th2 frequency, and the plasma IL-10 and IFN-γ more commonly coincided with, rather than predicted, the activity of GVHD. These markers are significantly higher when acute or chronic GVHD developed. The kinetics of IL-10 is especially correlated well with the activity of GVHD during clinical course of immunosuppressive treatment. For patients with hepatic GVHD, there is a positive correlation between plasma IL-10 levels and the severity of hepatic injury. The frequency of Th2 is also significant higher in acute GVHD and tends to be higher in chronic GVHD. Interestingly, there is a very good positive correlation between the frequency of Th1 and Th2 (r = 0.951, p<0.001). The plasma level of IL-4 and IL-12 are not associated with the activity of GVHD.ConclusionsThe frequency of Th1, Th2 within CD4+ T cells and plasma IL-10 and IFN-γ are good biomarkers of GVHD. Plasma IL-10 can also be used to monitor the therapeutic responsiveness. Furthermore, both Th1 and Th2 likely contribute to the pathogenesis of GVHD.

Highlights

  • graft-versus-host disease (GVHD) is a major complication after allogeneic hematopoietic stem cell transplantation (HSCT)

  • Plasma IL-10 can be used to monitor the therapeutic responsiveness. Both T helper1 (Th1) and T helper2 (Th2) likely contribute to the pathogenesis of GVHD

  • Using 4 pg/ml as cut off value, a plasma IL-10 level lower than 4 pg/ml is associated with a 95% negative predict rate of GVHD

Read more

Summary

Introduction

GVHD is a major complication after allogeneic hematopoietic stem cell transplantation (HSCT). It was unknown whether level of cytokines is associated with severity of GVHD [10,12,13,14,15,16,17,19]. Patients getting infection after myeloid engraftment were excluded from analysis With these efforts, we can continuously monitor the dynamic change of immune status ( plasma IFN-c, IL-4, Il-10, IL-12 levels, and the Th1, and Th2 frequencies within total CD4+ T cells simultaneously) and to establish the relationship between kinetics of immune status and the clinical activity of both acute and chronic GVHD

Design and Methods
Results
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.